ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
A case of dopa-responsive dystonia with a novel GCH1 variant c.579 C > G (p.Ile193Met).
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDopa-responsive dystonia (DRD) is an underdiagnosed inherited movement disorder characterized by childhood-onset progressive dystonia, diurnal symptom luctuation, and exquisite responsiveness to low-dose levodopa. Misdiagnosis as epilepsy, cerebral palsy, or juvenile Parkinsonism is common due to overlapping phenotypes and non-specific auxiliary examinations. CASE PRESENTATION: A 22-year-old Chinese female presented with an 18-year history of right-sided limb and perioral involuntary movements, slurred speech, and progressive hypertonia. She was misdiagnosed with epilepsy for over a decade with no response to antiepileptic therapy. Brain MRI, EEG, and routine laboratory tests were unremarkable. Whole-exome sequencing (WES) identiied a heterozygous guanosine triphosphate cyclohydrolase-1 (GCH1) variant c.579C>G (p.Ile193Met), classified as a variant of uncertain signiicance (VUS) per American College of Medical Genetics and Genomics (ACMG) guidelines. Low-dose levodopa/benserazide (Madopar 0.125 g tid) induced dramatic symptomatic improvement, with sustained remission at 6-month follow-up.
conclusionThis case expands the GCH1 mutational spectrum of DRD and highlights the critical role of levodopa trial in unexplained dystonia, even in the absence of diurnal luctuation. Early recognition and intervention are pivotal for favorable prognosis.
Indexed as
Identifiers
42154052What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.